For Clinical Labs
In today’s diagnostic landscape, laboratories must deliver fast, reliable, and cost-effective results despite staffing shortages, tighter regulations, and rising technical complexity.
Ascentry Launches Advisory Board to Drive Strategic Growth
Ascentry, leader in healthcare data management solutions, is proud to announce the creation of its Advisory Board, designed to provide guidance on the company’s strategic development and strengthen its position in the In Vitro Diagnostics (IVD) market. Ascentry is a trusted partner to leading IVD manufacturers and major LIS/HIS providers, with a proven track record of helping laboratories improve efficiency, connectivity, and overall user experience.
Ascentry is honored to welcome Joan Martin and Michael Iskra as members of this newly formed Advisory Board. Both bring extensive experience and deep expertise in the IVD industry, having held key leadership roles within major international groups.
Throughout their careers, Joan Martin and Michael Iskra have demonstrated a strong ability to drive innovation, build sustainable growth strategies, and navigate complex global organizations. Beyond their professional achievements, they are also recognized for their strong human values, which are fully aligned with Ascentry’s culture and long-term vision.
“The creation of this Advisory Board marks an important milestone for Ascentry” said Cyril Verhille, CEO of Ascentry. “Joan Martin and Michael Iskra bring an exceptional level of expertise in the IVD industry, combined with a deep understanding of international markets. Their strategic insight will be invaluable as we accelerate our growth.” He added: “What particularly resonated with us is their strong alignment with Ascentry’s human values. We are convinced that their experience and mindset will help us build sustainable, responsible growth while remaining true to our identity.”
Michael Iskra, member of Ascentry’s Advisory Board, commented: “Ascentry has a strong value proposition and a clear ambition for growth. I look forward to providing guidance to the team in accelerating market adoption and expanding Ascentry’s footprint especially in the U.S. market. There is significant potential to scale the business through focused execution and customer-centric marketing strategies.”
Joan Martin, also a member of Ascentry’s Advisory Board, added: “Ascentry has developed over the years valuable and smart data management systems and a rich portfolio that is able to provide high value for Clinical Labs and IVD industry; this offers a strong foundation for growing both globally and in EMEA markets beyond France. Looking forward to providing guidance the team in driving commercial execution, strengthening customer relationships, and accelerating sales performance across the region.”
The Advisory Board will provide strategic guidance to Ascentry’s leadership team, offering insights on market dynamics, industry trends, and organizational development, while supporting the company’s ambition to create long-term value.
With the creation of this Advisory Board, Ascentry reaffirms its commitment to excellence, innovation, and people-centered growth, supported by trusted and highly respected industry leaders.